CC260

Overview

CC260 is a selective PI5P4Kα and PI5P4Kβ inhibitor with K i s of 40 nM and 30 nM, respectively. CC260 does not inhibit or weakly inhibits other protein kinases, such as Plk1 and RSK2 . CC260 can be used for cell energy metabolism, diabetes and cancer research.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PI5P4K

Product Information

• Catalog No.: HY-139188
• CAS No.: 2411088-26-9
• Molecular Formula: C24H29Cl2N5O2
• Molecular Weight: 490.43
• Purity: 99.45%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 4 mg/mL (8.16 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source